Showing 581 - 600 results of 2,564 for search '(( significant decrease decrease ) OR ( significant ((non decrease) OR (a decrease)) ))~', query time: 0.39s Refine Results
  1. 581
  2. 582

    <i>Oenocarpus bacaba</i> palm tree (A) and fruit (B). by Eudes Alves Simões-Neto (19697968)

    Published 2024
    “…Managing ACD remains challenging even after more than 100 years of its discovery. Its spread to non-endemic areas has made it a global health issue. …”
  3. 583

    Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

    Published 2025
    “…The risk of cardiovascular death was significantly decreased (HR 0.64, 95% CI 0.41–0.998, <i>P</i> = 0.049) and the risk of fracture non-significantly increased (HR 1.47, 95% CI 0.95–2.27, <i>P</i> = 0.08) in the intervention group compared to the control group.…”
  4. 584

    Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

    Published 2025
    “…The risk of cardiovascular death was significantly decreased (HR 0.64, 95% CI 0.41–0.998, <i>P</i> = 0.049) and the risk of fracture non-significantly increased (HR 1.47, 95% CI 0.95–2.27, <i>P</i> = 0.08) in the intervention group compared to the control group.…”
  5. 585

    Prevaelnce of different pathogens by location. by Amete Mihret Teshale (12072758)

    Published 2025
    “…Non-typhoidal <i>Salmonella</i> (NTS), Shiga toxin-producing <i>Escherichia coli</i> (STEC), and <i>Campylobacter</i> species (CAMPY) significantly contribute to this burden. …”
  6. 586

    Table 1_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.doc... by Yiping Cao (1229856)

    Published 2024
    “…Pharmacological activation of local PVT A<sub>2A</sub>R with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …”
  7. 587

    Image 1_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.tif by Yiping Cao (1229856)

    Published 2024
    “…Pharmacological activation of local PVT A<sub>2A</sub>R with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …”
  8. 588

    Image 2_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.tif by Yiping Cao (1229856)

    Published 2024
    “…Pharmacological activation of local PVT A<sub>2A</sub>R with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …”
  9. 589

    Fig 3 - by Micha Keller (11312748)

    Published 2025
    “…Due to non-significant main effect of ‘time’, means across measurement days are plotted. …”
  10. 590

    Characteristics of Study Participants. by Hyelim Lee (11286822)

    Published 2025
    “…Sensitivity analyses confirmed a significantly lower HWP risk in the non-deficiency group under the lowered TG criterion and also showed that, in the three-category classification of vitamin D status, the non-deficiency group had a significantly lower HWP risk than the severe deficiency group, with a decreasing trend as vitamin D levels increased. …”
  11. 591
  12. 592

    Connectivity between the left nucleus accumbens and two clusters. by Karel Joineau (21799908)

    Published 2025
    “…After intervention there was a significant decrease in the FR group (mean at V1: 0.249 ± 0.094, mean at V5: 0.130 ± 0.101, difference: −0.119 ± 0.097, p < 0.001) and a significant increase in the SM group (mean at V1: 0.156 ± 0.113, mean at V5: 0.287 ± 0.107, difference: 0.131 ± 0.066, p < 0.001). …”
  13. 593

    Primer sequences for RT-qPCR. by Wenlong Shen (9313937)

    Published 2025
    “…Data from TCGA showed that NCOA4 shows greater downgrade in tumor tissues than in non-tumor tissues and the overall survival (OS) of patients with low NCOA4 expression was significantly shorter than that of patients with high NCOA4 expression.The qPCR results showed that NCOA4 was expressed at low levels in cholangiocarcinoma tissue specimens; the mRNA expression of NCOA4 decreased after knocking down NCOA4 in cells. …”
  14. 594

    siRNA sequences and negative controls sequences. by Wenlong Shen (9313937)

    Published 2025
    “…Data from TCGA showed that NCOA4 shows greater downgrade in tumor tissues than in non-tumor tissues and the overall survival (OS) of patients with low NCOA4 expression was significantly shorter than that of patients with high NCOA4 expression.The qPCR results showed that NCOA4 was expressed at low levels in cholangiocarcinoma tissue specimens; the mRNA expression of NCOA4 decreased after knocking down NCOA4 in cells. …”
  15. 595

    Antibodies used in the study. by Wenlong Shen (9313937)

    Published 2025
    “…Data from TCGA showed that NCOA4 shows greater downgrade in tumor tissues than in non-tumor tissues and the overall survival (OS) of patients with low NCOA4 expression was significantly shorter than that of patients with high NCOA4 expression.The qPCR results showed that NCOA4 was expressed at low levels in cholangiocarcinoma tissue specimens; the mRNA expression of NCOA4 decreased after knocking down NCOA4 in cells. …”
  16. 596

    Data supporting this article. by Karel Joineau (21799908)

    Published 2025
    “…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
  17. 597

    Demographic and clinical data at baseline. by Karel Joineau (21799908)

    Published 2025
    “…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
  18. 598

    Changes in clinical variables. by Karel Joineau (21799908)

    Published 2025
    “…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
  19. 599
  20. 600